On the one hand, active PERK/eIF2α signaling has been suggested to have oncogenic potential in CRC, whereas on the other hand, a more tumor-suppressive role of PERK in CRC has been documented [159,160,161,162,163]. Here, EIF2A is linked to colorectal carcinoma.